<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="marinedrugs-17-00567-t007" orientation="portrait" position="float">
 <object-id pub-id-type="pii">marinedrugs-17-00567-t007_Table 7</object-id>
 <label>Table 7</label>
 <caption>
  <p>In vivo anti-HIV-1 activity of GRFT in animal models.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Models Used</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dose Tested</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effects of GRFT</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guinea pig
     <break/>BALB/c mice
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single 50 mg/kg and 10 daily subcutaneous injections of 10 mg/kg.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retention of antiviral activity in serum</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B41-marinedrugs-17-00567" ref-type="bibr">41</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sprague Dawley (SD) rats</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A single dose of 10 mg/mL intravenously or subcutaneously.
     <break/>Ten 40 mg/kg doses for 10 days.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutralization activity found in fecal extracts</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B46-marinedrugs-17-00567" ref-type="bibr">46</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Humanized bone marrow-liver-thymus mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10
     <sup>8</sup> GRFT-expressing recombinant 
     <italic>C. crescentus</italic> intravaginally.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protection against HIV-1 infection</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B47-marinedrugs-17-00567" ref-type="bibr">47</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
